ZIP10 is one of four genes as a signature of poor survival in glioblastoma (257), and ZIP4 is increased in hepatocellular cancer (258) and likely to increase resistance to treatment in pancreatic cancer by preventing drug uptake (259). Here, SLC39A4 is linked to pancreatic neoplasm.